THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022

Shares 158,470 Value ($000) $1,778 Avg Close $10.51 Range $9.56 - $11.83

Q3 2022

Shares 110,350 Value ($000) $1,119 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 63,650 Value ($000) $577 Avg Close $9.21 Range $8.15 - $10.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2022	158,470	$1,778	$10.51	$9.56 - $11.83
Q3 2022	110,350	$1,119	$9.37	$7.53 - $11.00
Q2 2022	63,650	$577	$9.21	$8.15 - $10.52